Elizabeth McKee Anderson

Ms. Anderson has been a member of our board since November 2018, bringing more than 30 years of leadership in biotechnology, pharmaceuticals, and vaccines. Ms. Anderson held senior leadership positions at Johnson & Johnson between 2003 and her retirement in 2014. She most recently served as Worldwide Vice President, Infectious Disease and Vaccines for Janssen Pharmaceuticals, a Johnson & Johnson company, where she directed the commercial development of an extensive portfolio of antivirals and vaccines with responsibility for global strategic marketing, market access, and global analytics for that division. Prior to Johnson & Johnson, Ms. Anderson served as the Vice President and General Manager of Wyeth Lederle Vaccines from 1997 to 2002. She also previously worked at Rhone Poulenc Rorer and the American Red Cross. Ms. Anderson serves on the boards of directors of the private companies Aro Biotherapeutics Inc., REVOLUTION Medicines Inc., and Context Therapeutics, Inc., and the public companies Bavarian Nordic A/S and BioMarin Pharmaceutical Inc. She holds a Bachelor of Science in Engineering from Rutgers University and a Master of Business Administration from Loyola University Maryland. Ms. Anderson is chair of the Nominations & Governance Committee.